Brian Morris | Hypertension | Best Academic Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Dr. Brian Morris | Hypertension | Best Academic Researcher Award

University Of Sydney | Australia

Professor Dr. Brian Morris is a highly respected biomedical scientist and Professor Emeritus at the School of Medical Sciences, University of Sydney, acclaimed for his groundbreaking research in molecular medical sciences, hypertension, and public health. Throughout his distinguished career, he has made substantial contributions to understanding the genetic and molecular foundations of cardiovascular disease and ageing. He has held several prominent academic positions, including Professor of Molecular Medical Sciences and Senior Lecturer in Physiology, and has provided influential leadership in organizing international scientific conferences, such as the first global meeting on the molecular genetics of hypertension. Professor Morris has also served on major national and international research committees, editorial boards, and review panels, and is recognized as an exceptional mentor whose students have gone on to achieve senior positions in academia and industry worldwide. His numerous honors and fellowships from prestigious organizations reflect his exceptional contributions to science and education. With a prolific publication record of 404 documents, his research has received 11,835 citations from 8,579 documents, achieving an h-index of 56. His studies, published in leading journals including Circulation, Nature Genetics, PNAS, and Hypertension, have influenced scientific thought globally. His pioneering patent for the first use of PCR in viral detection further underscores his lasting impact on molecular diagnostics. Through his scientific innovation, academic leadership, and lifelong dedication to advancing knowledge, Professor Morris has made enduring contributions to cardiovascular and molecular health research worldwide.

Profiles: Scopus | Orcid

Featured Publications

Sarman, G., Cox, G., & Morris, B. J. (2025). Critique of “The impact of foot reflexology on postoperative pain and fear in children following circumcision: A randomized controlled trial.” Journal of Pediatric Urology.

Cox, G., & Morris, B. J. (2025). Comments on Fendereski et al., Comparing penile problems in circumcised vs. uncircumcised boys: Insights from a large commercial claims database with a focus on provider type performing circumcision. Journal of Pediatric Surgery.

Chen, R., Donlon, T. A., Morris, B. J., Allsopp, R. C., Willcox, B. J., & Masaki, K. H. (2024). Association of alcohol with lung cancer risk in men with different growth hormone receptor genotypes. Lung Cancer.

Chen, R., Morris, B. J., Donlon, T. A., Nakagawa, K., Allsopp, R. C., Willcox, B. J., Masaki, K. H., & Lipsitz, L. A. (2024). FOXO3 longevity genotype mitigates risk posed by hypertension on incident coronary artery disease in middle-aged men: Kuakini Honolulu Heart Program. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences.

Morris, B. J., & Banerjee, J. (2024). Comment on ‘Changing relationships between HIV prevalence and circumcision in Lesotho’, and ‘Age-incidence and prevalence of HIV among intact and circumcised men: an analysis of PHIA surveys in Southern Africa’. Journal of Biosocial Science.

Morris, B. J., & Klausner, J. D. (2024). Detrimental to public health: Royal Australasian College of Physicians’ recent policy on infant circumcision. Pediatric Research.

Hossam Elbenawi | Cardiac Electrophysiology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Hossam Elbenawi | Cardiac Electrophysiology | Best Researcher Award

Mayo Clinic | United States

Dr. Hossam Elbenawi is a dedicated physician and clinical researcher specializing in cardiovascular medicine, currently serving as a Postdoctoral Clinical Research Fellow at the Cardiovascular Research Institute, Mayo Clinic, Rochester, Minnesota. He earned his Bachelor of Medicine and Surgery from the Mansoura Manchester Program for Medical Education, Egypt, where he was trained under a problem-based learning curriculum emphasizing hands-on clinical exposure. His professional journey encompasses diverse clinical experiences across Egypt and the United States, including observerships and externships at leading institutions such as the Mayo Clinic, University of Minnesota, Allina Abbott Northwestern Hospital, and the Texas Heart Institute. Dr. Elbenawi’s research interests center on cardiovascular diseases, interventional cardiology, and cardiac imaging, contributing to his growing presence in the scientific community with 26 citations across 20 publications and an h-index of 3. Beyond clinical and academic work, he has demonstrated strong commitment to public health through extensive volunteer and community outreach initiatives, including medical awareness campaigns on diabetes, hypertension, and cancer prevention. His technical proficiency with medical software systems like Epic and Microsoft Office enhances his efficiency in both clinical documentation and research collaboration. Known for his professionalism, adaptability, and dedication to advancing patient care, Dr. Elbenawi continues to contribute meaningfully to cardiovascular research and global medical education.

Profile: Scopus

Featured Publications

Ghorbanzadeh, A., Liedl, D., Elbenawi, H., Rooke, T., Wennberg, P., McBane, R. D., & Houghton, D. E. (2025). Relationship between calf muscle pump function and severity of chronic venous disease. Vascular Medicine (London, England).

Amin, A. M., Elbenawi, H., Khan, U., Almaadawy, O., Turkmani, M., Abdelmottaleb, W., Essa, M., Abuelazm, M., Abdelazeem, B., Asad, Z. U. A., Deshmukh, A., Link, M. S., & DeSimone, C. V. (2025). Impact of diagnosis to ablation time on recurrence of atrial fibrillation and clinical outcomes after catheter ablation: A systematic review and meta-analysis with reconstructed time-to-event data. Circulation: Arrhythmia and Electrophysiology.

Abuelazm, M., Ibrahim, A. A., Amin, A. M., Shaaban Abdelgalil, M., Khan, U., Rezq, H., Elbenawi, H., Abuelazm, M. T., Turkmani, M., Abdelazeem, B., Bianco, C., & Balla, S. (2025). Exercise-based cardiac rehabilitation in patients with left ventricular assist devices: An updated systematic review and meta-analysis of randomized controlled trials. Expert Review of Medical Devices.

Amin, A. M., Ghaly, R., Elbenawi, H., Ewis, A., Khan, U., Elshaer, K. S. M., Abuelazm, M., Abdelazeem, B., Patel, B., Timimi, F. K., & Elgendy, I. Y. (2025). Impact of advanced lung cancer inflammation index on all-cause mortality among patients with heart failure: A systematic review and meta-analysis with reconstructed time-to-event data. Cardio-Oncology (London, England), 11(1), 9.

Amin, A. M., Elbenawi, H., Odat, R. M., Elgebaly, M., Al-Shammari, A. S., Manasrah, A., Nakhla, M., Ayman, D., Ali, M. A., Helmi, A., Abuelazm, M., Ternes, C. M. P., Abdelazeem, B., Zeb, I., Deshmukh, A. J., DeSimone, C. V., & d'Avila, A. (2025). Impact of anemia on clinical outcomes in atrial fibrillation patients on oral anticoagulants: A prognostic meta-analysis. Journal of Cardiovascular Electrophysiology.

 

Runze Wen | Cardiac Imaging | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Runze Wen | Cardiac Imaging | Best Researcher Award

The First Affiliated Hospital of University of Science and Technology | China

Dr. Runze Wen is an emerging scholar in the field of Cardiac Nuclear Medicine, currently pursuing his doctoral degree at the University of Science and Technology of China. His research focuses on advancing nuclear imaging techniques for cardiovascular diagnostics, with a strong emphasis on enhancing the precision and clinical applicability of cardiac assessments. Despite being at an early stage in his academic career, Dr. Wen has already demonstrated remarkable productivity and impact within the scientific community, with 3 published documents, 13 citations across 13 referencing works, and an h index of 3, a clear indication of the relevance and influence of his research. His investigations often integrate nuclear imaging modalities with innovative diagnostic approaches to improve the understanding of coronary microvascular dysfunction and other complex cardiac conditions. In addition to his academic achievements, Dr. Wen is a Fellow in Training (FIT) member of the American College of Cardiology (ACC), reflecting his commitment to professional development and international collaboration within the cardiology field. His ability to bridge advanced imaging science with clinical cardiology has earned him recognition as a promising young researcher dedicated to transforming cardiovascular diagnostics. Through his ongoing research and active engagement in academic circles, Dr. Runze Wen continues to contribute meaningfully to the future of nuclear cardiology, aiming to enhance patient care through evidence based innovation and interdisciplinary research excellence.

Profiles: Scopus | Orcid

Featured Publications

Wen, R., Xie, Q., Pan, B., Ni, M., Zhu, X., Meng, X., Wei, Z., Wu, X., Li, D., & Wang, X. (2025). Simultaneous 13N-ammonia and gadolinium perfusion using integrated PET–MRI: Diagnostic accuracy in coronary microvascular dysfunction. Frontiers in Medicine

Wen, R., Zhao, M., Chen, C., Yang, Y., & Zhang, B. (2023). A novel nomogram integrated with preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio to predict the therapeutic response of intermediate- and high-risk differentiated thyroid cancer patients: A bi-center retrospective study.

Hajime Kataoka | Heart Failure | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Hajime Kataoka | Heart Failure | Best Researcher Award

Nishida Hospital | Japan

Dr. Hajime Kataoka is a distinguished Cardiologist and Physician-Scientist at Nishida Hospital, Oita, Japan, widely recognized for his pioneering contributions to cardiovascular medicine. He has devoted his career to advancing the understanding, diagnosis, and treatment of cardiovascular diseases, with particular expertise in clinical electrocardiography and heart failure. His research focuses on body fluid status and cardio-renal interactions in patients with heart failure, exploring how electrolyte balance influences cardiac function and disease progression. Dr. Kataoka is best known for developing the groundbreaking “chloride theory” of heart failure pathophysiology, which redefines traditional perspectives by emphasizing chloride’s key role in regulating body fluid distribution and congestion, surpassing the conventional sodium-based understanding. This innovative theory has significantly influenced modern approaches to assessing diuretic response, predicting prognosis, and optimizing treatment strategies in heart failure management. With 107 published documents, 1,101 citations from 816 citing documents, and an h-index of 19, Dr. Kataoka has made a lasting impact on cardiovascular research and clinical practice. His scientific insights continue to inspire new investigations into electrolyte physiology, fluid regulation, and therapeutic innovation, solidifying his reputation as a thought leader in contemporary cardiology and as a driving force behind transformative advances in the field.

Profiles: Scopus | Orcid

Featured Publications

Kataoka, H. (2023). Acetazolamide as a potent chloride-regaining diuretic: Time to re-evaluate its diverse actions. Polish Archives of Internal Medicine.

Kataoka, H. (2022). Estimation of plasma renin activity on the basis of serum and urinary chloride concentrations versus sodium concentrations. Cardiorenal Medicine.

Kataoka, H. (2022). Mechanistic insights into chloride-related heart failure progression according to the plasma volume status. ESC Heart Failure.

Kataoka, H. (2020). Comparison of changes in plasma volume and renal function between acetazolamide and conventional diuretics: Understanding the mechanical differences according to their effects. Cardiology.

Kataoka, H., & Yoshida, Y. (2020). Enhancement of the serum chloride concentration by administration of sodium-glucose cotransporter-2 inhibitor and its mechanisms and clinical significance in type 2 diabetic patients: A pilot study. Diabetology & Metabolic Syndrome.

Xinke Wang | Heart Failure | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Ms. Xinke Wang | Heart Failure | Best Researcher Award

China Medical University | China

Ms. Xinke Wang is a dedicated researcher and master’s scholar at China Medical University, specializing in cardiovascular diseases with a particular focus on heart failure. Her academic background integrates clinical and epidemiological research, emphasizing the translation of basic scientific discoveries into effective clinical applications. Through her work, she strives to elucidate novel mechanisms underlying heart failure progression and identify innovative therapeutic strategies to improve patient care and outcomes. Ms. Wang has contributed significantly to various aspects of research, including data curation, conceptualization, methodology design, software development, formal analysis, validation, and manuscript preparation. Her ability to bridge clinical insight with analytical expertise underscores her commitment to advancing cardiovascular medicine. Collaborating with esteemed institutions such as Kailuan General Hospital, she actively engages in multidisciplinary research aimed at improving diagnostic precision and treatment efficacy in heart failure management. Her growing body of work reflects both academic rigor and practical relevance, contributing to the evolving landscape of cardiovascular research. Ms. Wang’s scholarly efforts exemplify a strong dedication to medical innovation, evidence-based practice, and collaborative science. By combining her expertise in epidemiology with a passion for clinical application, she continues to advance the understanding of cardiovascular health and disease, fostering new approaches that hold promise for enhancing patient outcomes and shaping the future of cardiovascular research.

Profile: Orcid

Featured Publication

Wang, X., Ning, N., Li, Y., Huang, R., Liu, Y., Miao, Y., Zhang, W., Chen, S., Gao, J., Wu, S., et al. (2025). Association of scores on the Life’s Essential 8 scale with progression to type 2 diabetes, heart failure, and death: A multistate Markov model analysis. Maturitas.

Maheshkumar Baladaniya | Cardiac Rehabilitation | Industry Impact Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Maheshkumar Baladaniya | Cardiac Rehabilitation | Industry Impact Award

Neighborhood Physical Therapy PC | United States

Dr. Maheshkumar Baladaniya, PT, MS, DPT, is a highly accomplished and licensed Physical Therapist recognized for his extensive expertise in clinical rehabilitation, healthcare management, and research. Currently serving as Clinical Director at Neighborhood PT PC in New City, NY, he brings a decade of progressive experience in patient care, program leadership, and interdisciplinary coordination. His clinical focus spans pediatric, geriatric, neuro, orthopedic, sports, and cardiopulmonary rehabilitation, where he integrates evidence-based therapeutic approaches to enhance functional recovery and quality of life. Dr. Baladaniya has successfully developed and implemented innovative rehabilitation programs, supervised multidisciplinary teams, and contributed to quality improvement initiatives across clinical settings. He holds a Doctor of Physical Therapy from the University of Montana, USA, a Master of Science in Health Informatics from the American College of Commerce and Technology, VA, and dual Master’s degrees in Physiotherapy (Sports and Neurology) from the National Institute of Medical Science, Jaipur, India, along with a Bachelor’s degree in Physiotherapy from Acharya Institute of Health Sciences, Bangalore, India. In addition to his clinical and leadership roles, Dr. Baladaniya is an active researcher with 24 published documents, 74 citations, and an h-index of 4, underscoring his academic impact and commitment to advancing rehabilitation science. His professional journey reflects dedication to excellence in patient-centered care, clinical innovation, and lifelong learning in physical therapy.

Profiles: Orcid | Google Scholar

Featured Publications

Baladaniya, M. (2024). Epidemiological study on developmental coordination disorder in school-going children. Journal of Pediatrics Research Reviews & Reports.

Baldania, S., & Baladaniya, M. (2024). Heart and lung dysfunction prevention through rehabilitation and physical therapy education: A comprehensive overview. Journal of Cardiology Research Review & Reports.

Baladaniya, M., & Baldania, S. (2024). Intersectionality in neurodevelopmental disorders: A literature review on co-occurrence of autism spectrum disorder and attention-deficit/hyperactivity disorder – Examining therapeutic approaches and interventions. International Journal of Health Sciences.

Baladaniya, M., & Gulrandhe, P. (2024). Shoulder and elbow synergy for lateral epicondylalgia management: A case report. Journal of Clinical and Diagnostic Research.

Baladaniya, M., & Korat, A. S. (2024). The impact of digital technology use on child development: A comprehensive literature review. Journal of Pediatrics Research Reviews & Reports.

Yifan Zhou | Cardiovascular Disease | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Yifan Zhou | Cardiovascular Disease | Best Researcher Award

Hunan Normal University | China

Dr. Yifan Zhou is a dedicated researcher in the field of orthopedics, with a strong focus on musculoskeletal health, metabolic regulation, and their interrelated effects on chronic diseases. Affiliated with prominent medical institutions in China, he has made meaningful contributions to understanding how metabolic and physiological factors influence skeletal muscle mass, body composition, and overall health outcomes. He has published 3 scientific documents, achieving an h-index of 1 and a total of 4 citations from 4 referencing sources, reflecting the growing recognition of his work within the scientific community. His studies have explored key associations such as the relationship between the metabolic score for visceral fat index and skeletal muscle mass, the role of the cardiometabolic index in obstructive sleep apnea, and the link between liver function indicators and sarcopenia among middle-aged adults. Additionally, his work examines the connection between the triglyceride-glucose index and depression, highlighting the mediating effects of hypertension and smoking in obese individuals. His research has been published in respected journals including Lipids in Health and Disease, Frontiers in Endocrinology, Frontiers in Nutrition, and the Journal of Affective Disorders. Beyond his research, he also contributes as a reviewer for major international journals such as Scientific Reports, European Spine Journal, BMC Public Health, and European Journal of Medical Research.

Profiles: Scopus | Orcid

Featured Publications

Zhou, Y., Su, X., Tan, H., & Xiao, J. (2024). Association between metabolic score for visceral fat index and BMI-adjusted skeletal muscle mass index in American adults. Lipids in Health and Disease.

Zhou, Y., Yu, J., Tan, H., & Xiao, J. (2024). Association between cardiometabolic index and obstructive sleep apnea and the mediating role of smoking: A cross-sectional study. Frontiers in Endocrinology (Lausanne).

Zhou, Y., Yu, J., Wu, A., Tan, H., & Xiao, J. (2024). Association between albumin–bilirubin score and sarcopenia in middle-aged Americans: A cross-sectional study. Frontiers in Nutrition.

Zhou, Y., Yu, J., Qi, L., Tan, H., & Xiao, J. (2024). Association between triglyceride–glucose index and depression and the mediating role of hypertension: A cross-sectional study of obese adults. Journal of Affective Disorders.

Tao Chen | Cardiovascular Mortality | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Tao Chen | Cardiovascular Mortality | Best Researcher Award

Fujian Medical University | China 

Tao Chen is a distinguished medical professional and researcher in the field of endocrinology and metabolism, currently serving as an Associate Chief Physician at the Affiliated Longyan First Hospital of Fujian Medical University and as a postgraduate tutor at Fujian Medical University. With extensive clinical and academic experience, he has played a vital role in medical education, scientific research, and the advancement of endocrine medicine. His primary research interests encompass diabetes, insulin resistance, metabolic disorders, osteoporosis, and the role of vitamin D in neuropathy. Tao Chen has published five scholarly papers focusing on topics such as glucose regulation, serum irisin levels and their relationship with insulin sensitivity, the effects of exercise on metabolic indicators, and vitamin D3-related complications in type 2 diabetes. His publications have collectively received 25 citations across 5 documents, and he holds an h-index of 3, reflecting his consistent contribution to clinical and academic research. Beyond research, he is actively involved in multiple professional organizations, serving as a council and committee member in various endocrinology and diabetes societies. He is also the Vice Chairman of the Osteoporosis and Bone Mineral Salt Disease Branch of the Longyan Medical Association and serves as a food and drug safety expert for the Longyan Municipal People’s Government. Through his ongoing leadership, research, and mentorship, Tao Chen continues to make meaningful contributions to endocrinology and medical science.

Profiles: Scopus | Orcid

Featured Publications

Lai, X., & Chen, T. (2024). Association of serum uric acid to high-density lipoprotein cholesterol ratio with all-cause and cardiovascular mortality in patients with diabetes or prediabetes: A prospective cohort study. Frontiers in Endocrinology.

Lai, X., & Chen, T. (2024). Association between the triglyceride–glucose index and serum soluble Klotho in middle-aged and older adults from NHANES 2007–2016. Scientific Reports.

Chen, T., Xing, X., Huang, L., Tu, M., Lai, X., Wen, S., Cai, J., Lin, S., Zheng, Y., Lin, Y., et al. (2023). Efficacy and safety of high-dose intramuscular vitamin D₂ injection in type 2 diabetes mellitus with distal symmetric polyneuropathy combined with vitamin D insufficiency: Study protocol for a multicenter, randomized, double-blinded, and placebo-controlled trial. Frontiers in Endocrinology.

Chen, T. (2022). Type 2 diabetes mellitus complicated with atherosclerotic cardiovascular disease patient treated with semaglutide: A case report. Chinese Journal of Diabetes.

Caicai Xi | Cardiovascular Researches | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Caicai Xi | Cardiovascular Researches | Best Researcher Award

Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University | China

Prof. Caicai Xi is a postdoctoral fellow at the College of Life Sciences, Zhejiang University, and holds a doctoral degree from Nanjing University of Chinese Medicine. Her research expertise lies in the total synthesis, extraction, separation, and biological evaluation of natural products derived from traditional Chinese medicine (TCM). She has also made significant contributions to the fields of production and synthetic biology of TCM resources, pharmacological and active material basis studies of TCM compound serum, and the development of hospital preparations and new drug formulations. Prof. Xi’s research aims to promote the rational utilization, modernization, and industrial application of TCM resources through scientific innovation and interdisciplinary integration. She has published 15 academic papers, which have collectively received 137 citations, and her work is reflected in an h-index of 3, indicating a growing academic impact in her area of specialization. Beyond her research publications, Prof. Xi has presided over and participated in 11 scientific research projects, contributed to the drafting of one technical standard, and co-authored one academic monograph. Recognized as a High-level Talent (Class E) in Zhejiang Province and Hangzhou City, she also holds positions in national professional organizations dedicated to TCM research and innovation. Her active participation in these scientific communities underscores her commitment to advancing the modernization and global relevance of traditional Chinese medicine through innovative research and collaborative development.

Profile: Scopus

Featured Publication

Wu, R., Wang, J., Zhou, H., Xue, X., Tong, C., Zhao, L., Wu, Y., Mei, X., Guo, Z., & Xi, C. (2025). Analysis of blood components and target prediction for the combined use of Dendrobium officinale compound and Western medicine in antihypertensive therapy based on network pharmacology and molecular docking. Drug Design, Development and Therapy

Ibtasam Wajid | Cardiovascular Diseases | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Mr. Ibtasam Wajid | Cardiovascular Diseases | Best Researcher Award

Shenzhen University | China

Mr. Ibtasam Wajid is an emerging researcher whose work focuses on the intersection of biomedical engineering, health informatics, and data science, with a particular interest in developing innovative machine learning and deep learning models for improving healthcare outcomes. His research explores how advanced computational techniques can be applied to disease prediction, medical imaging, and clinical decision support, contributing to the growing field of digital health transformation. With an academic background spanning biochemistry, health informatics, and biomedical research, he brings an interdisciplinary perspective to addressing complex challenges in modern medicine. He has authored three research documents, accumulating a total of six citations and holding an h-index of one, reflecting a steadily growing research impact at an early stage of his academic career. Alongside his research contributions, he has actively participated in mentoring undergraduate students, organizing technical workshops, and promoting collaborative learning environments within the scientific community. His ongoing studies and projects continue to focus on integrating artificial intelligence into healthcare systems to enhance accuracy, efficiency, and patient-centered care. Through his dedication to continuous learning and innovation, he demonstrates the potential to make lasting contributions to biomedical science and the advancement of data-driven healthcare solutions worldwide.

Profiles: Scopus | Google Scholar

Featured Publications

Sultan, H., Javed, I., Zubair, M., Iqbal, K., Bilal, M., Iqbal, J., & Wajid, I. (2021). Protein and polysaccharide-based biomaterial for the formation of composite bone scaffold. AlQalam Journal of Medical and Applied Sciences, 4(2), 80–88.

Wajid, I., Dan, L., & Wang, Q. (2025). Hybrid ensemble approaches for cardiovascular disease prediction: Leveraging interpretable AI for clinical insight. Intelligence-Based Medicine, 100297.

Ishaq, S., Afzal, S., Usmani, S. A., Wajid, I., Aziz, A., Tahir, R., Ahmad, A., & Ullah, A. (2025). Inflammatory cell death and leukemia treatment. Critical Reviews in Oncology/Hematology, 104909.